COVID-19 Treatment Candidates, at a Glance

More than a year into the pandemic, a handful of vaccines have been authorized for the novel coronavirus in the U.S., yet there is still no cure for COVID-19. Researchers and doctors have been racing to find drugs and therapies that could treat the disease or prevent people from getting infected. Only one drug, Gilead Sciences’ Veklury (remdesivir), has been approved by the FDA, while several treatments received an emergency use authorization (EUA). Here’s a look at some of the key treatments/candidates currently in play:

© 2023 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
November 22

News Briefs: CDC Makes More RSV Immunizations Available to Infants

READ MORE
dna-strand
November 22

Papers Delve Into Payment Options for Gene Therapies

READ MORE
pills
November 22

A Closer Look at the Medicare Part D Landscape

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today